Abstract

Applications of CRISPR technologies to the development of gene and cell therapy

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
1014 – CELLULAR SENESCENCE: AN UNINTENDED TWIST FOR GENE AND CELL THERAPY APPLICATIONS
Luigi Naldini ... Raffaella Di Micco
Experimental Hematology | VOL. 111
Luigi Naldini, et. al.Luigi Naldini ... Raffaella Di Micco
01 Jan 2021
Gene and Cell Therapies in Expansion Mode: ASGCT 2016
Cynthia E Dunbar
Molecular Therapy | VOL. 24
Cynthia E DunbarCynthia E Dunbar
01 Aug 2016
Expanded Opportunities for Methods and Clinical Development
Roland W Herzog
Molecular Therapy | VOL. 24
Roland W HerzogRoland W Herzog
01 Apr 2016
The Ultramarathon of Gene Therapy Development for Rare Diseases: How Can We Cross the Finish Line Together?
Erin Ward
Clinical Therapeutics | VOL. 44
Erin WardErin Ward
01 Aug 2022
View more papers

More From: BMB Reports

Paper Title
Journal
Date
Author
Characterization of an orthotopic mouse transplant model reveals early changes in the tumor microenvironment of lung cancer
Minsu Na ... Hae-Ock Lee
BMB Reports | VOL. -
Minsu Na, et. al.Minsu Na ... Hae-Ock Lee
21 May 2024
Increased ER stress by depletion of PDIA6 impairs primary ciliogenesis and enhances sensitivity to ferroptosis in kidney cells
Joon Bum Kim ... Dong-Hyung Cho
BMB Reports | VOL. -
Joon Bum Kim, et. al.Joon Bum Kim ... Dong-Hyung Cho
14 May 2024
T-plastin contributes to epithelial-mesenchymal transition in human lung cancer cells through FAK/AKT/Slug axis signaling pathway
Soon Yong Park ... Jin Woong Chung
BMB Reports | VOL. -
Soon Yong Park, et. al.Soon Yong Park ... Jin Woong Chung
08 May 2024
Genetic disruption of ATAT1 causes RhoA downregulation through abnormal truncation of C/EBPβ
Jee-Hye Choi ... Sangmyung Rhee
BMB Reports | VOL. -
Jee-Hye Choi, et. al.Jee-Hye Choi ... Sangmyung Rhee
03 May 2024
View more papers